By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker Energy & Supercon Technologies, a subsidiary of bruker, has filed for an initial public offering in the US. The firm did not say in the prospectus how many shares it intends to offer, and it listed $100 million as the estimated maximum aggregate offering price. Following the offering, parent firm Bruker will continue to hold the majority of shares in BEST, which sells superconducting materials used in applications, such as MRI, NMR, and fusion energy research.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.